Durviz, S. L. is a leader in biotechnology, providing products for diagnostic and research laboratories. The company offers instrumentation and reagents related to molecular biology, cellular biology, reproductive biology, and microbiology. With experienced teams and a commercial network in Valencia, Madrid, Barcelona, Bilbao, Granada, and La Coruña, Durviz aims to provide comprehensive support to its clients.
Since its establishment in 1979, Durviz has been committed to innovation and the provision of cutting-edge technologies to its customers. The company has achieved significant milestones, such as the introduction of microarray analysis and the incorporation of Solexa technology for massive sequencing into the Spanish market.
Operating in the biotechnology, health care, and medical devices industries, Durviz is headquartered in Spain. Currently, there is no publicly available information regarding the company's last investment or its associated investors.
There is no investment information
No recent news or press coverage available for Durviz, S. L..